NuWave Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,127
Closed -$631K 445
2021
Q1
$631K Buy
+4,127
New +$638K 0.8% 29
2020
Q4
Sell
-12
Closed -$1K 555
2020
Q3
$1K Sell
12
-140
-92% -$15.1K ﹤0.01% 527
2020
Q2
$17K Sell
152
-587
-79% -$62.3K 0.02% 288
2020
Q1
$66K Sell
739
-3,217
-81% -$316K 0.14% 125
2019
Q4
$428K Buy
3,956
+3,369
+574% +$360K 0.42% 88
2019
Q3
$58K Buy
587
+559
+1,996% +$63K 0.06% 240
2019
Q2
$4K Sell
28
-702
-96% -$90.5K ﹤0.01% 402
2019
Q1
$99K Buy
730
+216
+42% +$26.9K 0.12% 181
2018
Q4
$50K Buy
514
+460
+852% +$54.4K 0.09% 188
2018
Q3
$8K Buy
+54
New +$6.77K 0.01% 261
2014
Q3
Sell
-1,396
Closed -$219K 361
2014
Q2
$219K Buy
1,396
+860
+160% +$136K 0.56% 70
2014
Q1
$82K Buy
536
+510
+1,962% +$81.1K 0.24% 142
2013
Q4
$3K Sell
26
-15
-37% -$1.8K ﹤0.01% 280
2013
Q3
$5K Sell
41
-22
-35% -$2.41K ﹤0.01% 286
2013
Q2
$6K Buy
+63
New +$6.07K 0.01% 282

Other funds holding ALXN